Cargando…

Understanding barriers to and strategies for medication adherence in COPD: a qualitative study

BACKGROUND: Medication adherence in chronic obstructive pulmonary disease (COPD) is low, though not enough is known about the factors that affect adherence in COPD. This study uses qualitative methods to understand the patient perspective on facilitators and barriers to medication adherence in COPD...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Toole, Jacqueline, Krishnan, Meera, Riekert, Kristin, Eakin, Michelle N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934480/
https://www.ncbi.nlm.nih.gov/pubmed/35305609
http://dx.doi.org/10.1186/s12890-022-01892-5
_version_ 1784671858390466560
author O’Toole, Jacqueline
Krishnan, Meera
Riekert, Kristin
Eakin, Michelle N.
author_facet O’Toole, Jacqueline
Krishnan, Meera
Riekert, Kristin
Eakin, Michelle N.
author_sort O’Toole, Jacqueline
collection PubMed
description BACKGROUND: Medication adherence in chronic obstructive pulmonary disease (COPD) is low, though not enough is known about the factors that affect adherence in COPD. This study uses qualitative methods to understand the patient perspective on facilitators and barriers to medication adherence in COPD as well as patient-reported strategies for self-management of disease. METHODS: Semi-structured interviews were conducted with 30 individuals (n = 30). Transcripts were analyzed using iterative qualitative coding by 2 independent coders, and codes were categorized using thematic analysis. RESULTS: Challenges with adherence reported were gaps in understanding, forgetfulness of the patient, physician availability, cost navigation, and overcoming substance use. Most commonly, the financial burden of COPD medications caused patients to source other countries to obtain medications, rely on sample medications collected during doctors’ visits, and to alter medication dosage and frequency to extend the length of a prescription. Tools and resources reported by patients to support self-management of COPD included pharmacist assistance, physician office information, and community resources. Individuals further reported that the use of logs or diaries to track medication usage, visual or temporal cues to take medications, and support from family members were helpful in promoting adherence to their COPD medication regimen. CONCLUSIONS: Medication adherence in individuals with COPD is affected by challenges with self-management of disease and financial burden of medications. However, patients reported multiple tools and resources to support adherence. Physician recognition of these factors impacting self-management, as well as awareness of strategies to promote adherence and manage disease, may improve patient outcomes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-022-01892-5.
format Online
Article
Text
id pubmed-8934480
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89344802022-03-23 Understanding barriers to and strategies for medication adherence in COPD: a qualitative study O’Toole, Jacqueline Krishnan, Meera Riekert, Kristin Eakin, Michelle N. BMC Pulm Med Research BACKGROUND: Medication adherence in chronic obstructive pulmonary disease (COPD) is low, though not enough is known about the factors that affect adherence in COPD. This study uses qualitative methods to understand the patient perspective on facilitators and barriers to medication adherence in COPD as well as patient-reported strategies for self-management of disease. METHODS: Semi-structured interviews were conducted with 30 individuals (n = 30). Transcripts were analyzed using iterative qualitative coding by 2 independent coders, and codes were categorized using thematic analysis. RESULTS: Challenges with adherence reported were gaps in understanding, forgetfulness of the patient, physician availability, cost navigation, and overcoming substance use. Most commonly, the financial burden of COPD medications caused patients to source other countries to obtain medications, rely on sample medications collected during doctors’ visits, and to alter medication dosage and frequency to extend the length of a prescription. Tools and resources reported by patients to support self-management of COPD included pharmacist assistance, physician office information, and community resources. Individuals further reported that the use of logs or diaries to track medication usage, visual or temporal cues to take medications, and support from family members were helpful in promoting adherence to their COPD medication regimen. CONCLUSIONS: Medication adherence in individuals with COPD is affected by challenges with self-management of disease and financial burden of medications. However, patients reported multiple tools and resources to support adherence. Physician recognition of these factors impacting self-management, as well as awareness of strategies to promote adherence and manage disease, may improve patient outcomes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-022-01892-5. BioMed Central 2022-03-19 /pmc/articles/PMC8934480/ /pubmed/35305609 http://dx.doi.org/10.1186/s12890-022-01892-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
O’Toole, Jacqueline
Krishnan, Meera
Riekert, Kristin
Eakin, Michelle N.
Understanding barriers to and strategies for medication adherence in COPD: a qualitative study
title Understanding barriers to and strategies for medication adherence in COPD: a qualitative study
title_full Understanding barriers to and strategies for medication adherence in COPD: a qualitative study
title_fullStr Understanding barriers to and strategies for medication adherence in COPD: a qualitative study
title_full_unstemmed Understanding barriers to and strategies for medication adherence in COPD: a qualitative study
title_short Understanding barriers to and strategies for medication adherence in COPD: a qualitative study
title_sort understanding barriers to and strategies for medication adherence in copd: a qualitative study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934480/
https://www.ncbi.nlm.nih.gov/pubmed/35305609
http://dx.doi.org/10.1186/s12890-022-01892-5
work_keys_str_mv AT otoolejacqueline understandingbarrierstoandstrategiesformedicationadherenceincopdaqualitativestudy
AT krishnanmeera understandingbarrierstoandstrategiesformedicationadherenceincopdaqualitativestudy
AT riekertkristin understandingbarrierstoandstrategiesformedicationadherenceincopdaqualitativestudy
AT eakinmichellen understandingbarrierstoandstrategiesformedicationadherenceincopdaqualitativestudy